Odyssey Therapeutics, Inc. (ODTX)

Odyssey Therapeutics will go public soon, but the exact IPO date is still unknown.

Stock Price: Pending

IPO price not available yet

Odyssey Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Net Income	-122.25	-130.92	-124.67
Depreciation & Amortization	5.13	4.91	2.76
Share-Based Compensation	-	6.26	5.52
Other Operating Activities	8.28	2.04	16.54
Operating Cash Flow	-108.83	-112.73	-99.84
Capital Expenditures	-3.36	-5.06	-13.03
Change in Investments	-	-159.99	-
Other Investing Activities	-25.55	0.02	-
Investing Cash Flow	-28.91	-165.02	-13.03
Share Issuance / Repurchase	-	96.84	177.84
Debt Issued / Paid	-	-4.76	4.88
Financing Cash Flow	116.76	92.08	182.72
Net Cash Flow	-21	-185.67	69.83
Free Cash Flow	-112.2	-117.78	-112.87
Free Cash Flow Margin	-3734.95%	-11358.15%	-

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).